Shanghai, China · Founded 2015 · In IPO Registration
Researcher and developer of innovative drugs focused on oncology treatments. Convalife Pharmaceuticals is based in Shanghai, China and was founded in 2015. Its last reported valuation was $445 million in Jul 2025. It has raised $59.8 million.
Last reported valuation
$444.6M
Oct 2026
Priced at
—
Total raised
$59.8M
Last round
—
Cap table — not yet on record
Convalife Pharmaceuticals's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Convalife Pharmaceuticals with a free account
·The complete investor list: 12 names
·Watch Convalife Pharmaceuticals: the Monday email on marks, rounds and moves
